Swine Vaccines Market to Grow with a CAGR of 4.85% through 2030F

Rising demand for pork, the imperative need for disease prevention, and advancements in vaccine technology are expected to drive the Global Swine Vaccines Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Swine Vaccines Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Swine Vaccines Market stood at USD 1.32 billion in 2024 and is anticipated to grow with a CAGR of 4.85% in the forecast period, 2025-2030. This can be attributed to the adoption of biosecurity measures. Farmers are increasingly recognizing the importance of biosecurity measures in swine farming. Alongside vaccination, biosecurity practices such as controlled access to farms, quarantine protocols, and sanitation help prevent the introduction and spread of diseases. The combined use of vaccines and biosecurity measures enhances disease control and supports market growth.

The consumer preferences are driving changes in the swine industry, including vaccine usage. Consumers increasingly demand higher standards of animal welfare, antibiotic-free products, and environmentally sustainable practices. Swine vaccines play a role in meeting these demands by supporting healthier herds and reducing the need for antibiotics.

The COVID-19 pandemic disrupted the distribution of critically needed swine vaccines in the early months of 2020, resulting in significant losses for swine producers and vaccine manufacturers. This disruption was primarily due to global lockdowns and supply chain restrictions implemented to contain the spread of COVID-19. Governments and healthcare sectors were primarily focused on managing human emergency treatments during the crisis while also grappling with the increasing incidence of contagious swine diseases affecting the overall livestock industry. Various measures, including import and export bans, strengthened biosecurity protocols, routine surveillance, epidemiological investigations, and vaccination campaigns, were implemented in different regions to curb the spread of these diseases.

The companies in the market are introducing a range of innovative vaccine technologies and solutions, which are contributing to market growth. For example, in October 2019, Boehringer Ingelheim received authorization from the European Medicines Agency (EMA) for ReprocycParvoFLEX, the first subunit porcine parvovirus vaccine designed to protect swine fetuses against transplacental infection. The veterinary universities are actively providing vaccination services to assist small-scale swine farmers in implementing disease control measures. For instance, the College of Veterinary Medicine at the University of Illinois established a website to offer information and resources to pork producers for enhancing their on-farm biosecurity programs. Training farm employees and developing biosecurity plans are crucial steps in preventing the entry and spread of high-risk pathogens in swine farms, further contributing to market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Swine Vaccines Market”

The Global Swine Vaccines Market is segmented into product, type, target disease, regional distribution, and company.

Based on its product, recombinant vaccines is projected to experience the most rapid growth rate during the forecast period. These vaccines are expected to play a pivotal role in achieving immunization against a wide array of virus strains, as they have the capability to carry multiple gene inserts. An example of such a swine recombinant vaccine is IngelvacCircoFLEX, developed by Boehringer Ingelheim International GmbH, which offers active immunization for pigs aged two weeks and older. Formulated vaccines of this nature can enhance stability, viability, and eliminate the need for adjuvants. Some of the available recombinant vaccines for swine target diseases such as pseudorabies, porcine circovirus type 2, and classical swine fever (CSF).

Based on region, North America is the second-fastest-growing region in the global swine vaccines market, following Asia-Pacific. This growth is driven by high pork consumption, stringent biosecurity regulations, and increasing awareness among pig producers about disease prevention. The region has a well-established veterinary healthcare infrastructure and strong government support for disease control programs, particularly for Porcine Reproductive and Respiratory Syndrome (PRRS) and Porcine Circovirus (PCV). Additionally, advancements in vaccine technologies and the adoption of combination vaccines are fueling market expansion. The presence of leading vaccine manufacturers and ongoing investments in research and development further contribute to the rapid growth of North America's swine vaccine market.

Major companies operating in Global Swine Vaccines Market are:

·         Merck & Co Inc

·         Zoetis Inc

·         Boehringer Ingelheim GmbH

·         Elanco Animal Health Inc

·         Indian Immunologicals Ltd

·         Biogénesis Bagó

·         Phibro Animal Health Corp

·         Laboratorios HIPRA SA

·         Virbac SA

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global swine vaccines market is evolving to meet the complex challenges of disease prevention in a dynamic swine farming industry. Emerging trends such as precision vaccination, next-generation vaccine platforms, data-driven decisions, and enhanced biosecurity measures are shaping the future of swine vaccination. These developments not only contribute to healthier swine herds but also align with the demands of consumers for safe, high-quality, and sustainable pork products. As the swine industry continues to grow and adapt, staying attuned to these trends will be essential for success in the global swine vaccines market”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines), By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza), By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Swine Vaccines Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Swine Vaccines Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com